Lung Cancer Clinical Trial
To Assess the Effectiveness and Safety of Zepzelca in Adult Patients With Extensive Stage Small Cell Lung Cancer (SCLC)
To assess the effectiveness and safety of Zepzelca in adult participants with extensive stage small cell lung cancer (SCLC) in real-world clinical practice.
A phase IV, prospective, single arm, multi-center, observational study to collect safety and outcome data of Zepzelca in adult participants with extensive stage SCLC previously exposed to at least one line of treatment with platinum-based chemotherapy. Patients enrolled in the study will be encouraged to complete patient reported outcome (PRO) questionnaires.
Patient has initiated or will be receiving Zepzelca treatment in line with the local Zepzelca prescribing information.
Decision to initiate treatment with Zepzelca was made as per investigator's routine treatment practice prior to enrollment in the study.
Patient, or a legally acceptable representative, signed the informed consent before any study-related activities are undertaken.
Patients who discontinued a prior Zepzelca treatment due to adverse events.
Patient who received more than 2 cycles of Zepzelca treatment in their current treatment schedule.
Patient received treatment with any investigational agent within 30 days prior to first Zepzelca infusion or plans to use another investigational agent while receiving Zepzelca.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 48 Locations for this study
Huntsville Alabama, 35805, United States
Anaheim California, 92801, United States
Norwich Connecticut, 06360, United States
Brooksville Florida, 34613, United States
Pensacola Florida, 32503, United States
Boise Idaho, 83709, United States
Normal Illinois, 61761, United States
Goshen Indiana, 46526, United States
Sioux City Iowa, 51101, United States
Garden City Kansas, 67846, United States
Topeka Kansas, 66606, United States
Wichita Kansas, 67214, United States
Lexington Kentucky, 40503, United States
Pineville Kentucky, 41501, United States
Marrero Louisiana, 70072, United States
Farmington Hills Michigan, 48334, United States
Saint Louis Park Minnesota, 55426, United States
Pascagoula Mississippi, 39581, United States
Bolivar Missouri, 65613, United States
Great Falls Montana, 59404, United States
Omaha Nebraska, 68310, United States
Hackensack New Jersey, 07601, United States
Little Silver New Jersey, 07739, United States
Bronx New York, 10461, United States
Rochester New York, 14621, United States
Rocky Mount North Carolina, 27804, United States
Washington North Carolina, 27889, United States
Minot North Dakota, 58701, United States
Canton Ohio, 44718, United States
Massillon Ohio, 44646, United States
Wynnewood Pennsylvania, 19096, United States
Charleston South Carolina, 29414, United States
Rock Hill South Carolina, 29732, United States
West Columbia South Carolina, 29169, United States
Rapid City South Dakota, 57701, United States
Memphis Tennessee, 38120, United States
Houston Texas, 77089, United States
Temple Texas, 76508, United States
The Woodlands Texas, 77380, United States
Webster Texas, 77598, United States
Moncton New Brunswick, E1C 6, Canada
Ottawa Ontario, K1H 8, Canada
Toronto Ontario, M5G 2, Canada
Chicoutimi Quebec, G7H 7, Canada
Rimouski Quebec, G5L 5, Canada
Sherbrooke Quebec, J1H 5, Canada
Nova Scotia , B1P 1, Canada
Québec , G1V 4, Canada
How clear is this clinincal trial information?
Introducing, the Journey Bar
Use this bar to access information about the steps in your cancer journey.